|
Cell Phones, Driving, And Multitasking
Science 2.0 This may have some very interesting consequences in the near future, from bans on the use of some technologies (a la the NTSB stance or the cell phone ban in many schools), to the use of attention-boosting drugs such as Modafinil, to the proliferation … and more » |
|
The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma …
Sacramento Bee Important 2012 US generic launches for Mylan include Provigil, Diovan, Zyprexa, Plavix, Actos/Actoplus, Viramune, Clarinex, Singulair and Avapro. Teva, another force in the generic space, has drugs like Avandia, Avandamet, and Avandaryl, Actos/Actoplus … and more » |
|
The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma …
PR Newswire (press release) Important 2012 US generic launches for Mylan include Provigil, Diovan, Zyprexa, Plavix, Actos/Actoplus, Viramune, Clarinex, Singulair and Avapro. Teva, another force in the generic space, has drugs like Avandia, Avandamet, and Avandaryl, Actos/Actoplus … and more » |
|
The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma …
Zacks.com Important 2012 US generic launches for Mylan include Provigil, Diovan, Zyprexa, Plavix, Actos/Actoplus, Viramune, Clarinex, Singulair and Avapro. Teva, another force in the generic space, has drugs like Avandia, Avandamet, and Avandaryl, Actos/Actoplus … and more » |